Clinical Trial Update: PL_GNT01_ISR_Grant 53234273

View source ↗

Summary

A clinical trial update indicates that the PL_GNT01_ISR_Grant study (NCT06714019) is currently enrolling by invitation for transthyretin-related cardiomyopathy,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy
• Transthyretin Amyloidosis
• Transthyretin Cardiomyopathy

Snippet

Sponsor: National Institute of Cardiology, Warsaw, Poland | Conditions: Transthyretin Cardiomyopathy (TTR-CM), Transthyretin (TTR) Amyloid Cardiomyopathy | Status: ENROLLING_BY_INVITATION